TY - JOUR AU - Navarro-Torné, Adoración AU - Hanrahan, Finnian AU - Kerstiëns, Barbara AU - Aguar, Pilar AU - Matthiessen, Line T1 - Public Health–Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union T2 - Emerging Infectious Disease journal PY - 2019 VL - 25 IS - 2 SN - 1080-6059 AB - Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven limited, particularly in certain groups, such as the elderly. Moreover, preparedness for upcoming pandemics is challenging because we can predict neither the strain that will cause the next pandemic nor the severity of the pandemic. The European Union fosters research and innovation to develop novel vaccines that evoke broadly protective and long-lasting immune responses against both seasonal and pandemic influenza, underpinned by a political commitment to global public health. KW - influenza KW - influenza pandemic KW - influenza vaccines KW - biomedical research KW - innovation KW - financial support KW - European Union KW - global health KW - public health KW - drug legislation KW - vaccines KW - viruses DO - 10.3201/eid2502.180359 UR - https://wwwnc.cdc.gov/eid/article/25/2/18-0359_article ER - End of Reference